DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,767 filers reported holding DANAHER CORPORATION in Q4 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,477,876 | +133.9% | 42,233 | +126.2% | 0.30% | +11.8% |
| Q2 2023 | $4,480,080 | +16.5% | 18,667 | +22.4% | 0.27% | -2.9% |
| Q1 2023 | $3,844,115 | +11.5% | 15,252 | +17.4% | 0.28% | +3.7% |
| Q4 2022 | $3,448,602 | +4.1% | 12,993 | +1.3% | 0.27% | -11.5% |
| Q3 2022 | $3,313,000 | -14.4% | 12,827 | -16.0% | 0.30% | +1.0% |
| Q2 2022 | $3,871,000 | -7.4% | 15,270 | +7.1% | 0.30% | +6.3% |
| Q1 2022 | $4,181,000 | -7.8% | 14,253 | +3.5% | 0.28% | -7.8% |
| Q4 2021 | $4,533,000 | +16.8% | 13,777 | +8.0% | 0.31% | +6.2% |
| Q3 2021 | $3,882,000 | +4.8% | 12,751 | -7.6% | 0.29% | +1.8% |
| Q2 2021 | $3,703,000 | +18.6% | 13,800 | -0.5% | 0.28% | +9.6% |
| Q1 2021 | $3,121,000 | +5.5% | 13,867 | +4.1% | 0.26% | -3.3% |
| Q4 2020 | $2,959,000 | +31.3% | 13,321 | +27.3% | 0.27% | +11.6% |
| Q3 2020 | $2,253,000 | +22.0% | 10,463 | +0.2% | 0.24% | +13.1% |
| Q2 2020 | $1,846,000 | +24.9% | 10,438 | -2.3% | 0.21% | -0.9% |
| Q1 2020 | $1,478,000 | -17.6% | 10,680 | -8.6% | 0.22% | -1.4% |
| Q4 2019 | $1,794,000 | +18.0% | 11,690 | +11.1% | 0.22% | +7.4% |
| Q3 2019 | $1,520,000 | -4.2% | 10,523 | -5.1% | 0.20% | -3.8% |
| Q2 2019 | $1,586,000 | +9.0% | 11,094 | +0.6% | 0.21% | +5.0% |
| Q1 2019 | $1,455,000 | +24.3% | 11,024 | -2.9% | 0.20% | +10.4% |
| Q4 2018 | $1,171,000 | -6.5% | 11,353 | -1.4% | 0.18% | +5.8% |
| Q3 2018 | $1,252,000 | +9.9% | 11,520 | -0.2% | 0.17% | +6.2% |
| Q2 2018 | $1,139,000 | +3.5% | 11,545 | +2.6% | 0.16% | +1.2% |
| Q1 2018 | $1,101,000 | +5.8% | 11,248 | +0.3% | 0.16% | +13.5% |
| Q4 2017 | $1,041,000 | +11.7% | 11,219 | +3.3% | 0.14% | +16.5% |
| Q3 2017 | $932,000 | -3.9% | 10,864 | -5.4% | 0.12% | -14.8% |
| Q2 2017 | $970,000 | -4.2% | 11,489 | -3.0% | 0.14% | -3.4% |
| Q1 2017 | $1,013,000 | +19.0% | 11,849 | +8.3% | 0.15% | +6.5% |
| Q4 2016 | $851,000 | – | 10,939 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |